Lexaria Bioscience Corp. Quarterly Retained Earnings (Accumulated Deficit) in USD from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Lexaria Bioscience Corp. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q3 2010 to Q2 2024.
  • Lexaria Bioscience Corp. Retained Earnings (Accumulated Deficit) for the quarter ending May 31, 2024 was -$49.4M, a 10.9% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 -$49.4M -$4.85M -10.9% May 31, 2024 10-Q 2024-07-12
Q1 2024 -$47.6M -$5.44M -12.9% Feb 29, 2024 10-Q 2024-04-09
Q4 2023 -$46.9M -$6.09M -14.9% Nov 30, 2023 10-Q 2024-01-12
Q3 2023 -$45.8M -$6.66M -17% Aug 31, 2023 10-Q 2024-07-12
Q2 2023 -$44.5M -$6.89M -18.3% May 31, 2023 10-Q 2023-07-14
Q1 2023 -$42.2M -$6.9M -19.6% Feb 28, 2023 10-Q 2023-04-14
Q4 2022 -$40.9M -$7.03M -20.8% Nov 30, 2022 10-Q/A 2023-01-18
Q3 2022 -$39.1M -$7.27M -22.8% Aug 31, 2022 10-K 2023-11-20
Q2 2022 -$37.6M -$68.2M -223% May 31, 2022 10-Q 2022-07-14
Q1 2022 -$35.2M -$7.15M -25.5% Feb 28, 2022 10-Q 2022-04-11
Q4 2021 -$33.8M -$5.32M -18.7% Nov 30, 2021 10-Q 2022-01-14
Q3 2021 -$31.8M -$4.03M -14.5% Aug 31, 2021 10-K 2022-11-28
Q2 2021 $30.6M +$57.7M May 31, 2021 10-Q 2021-07-15
Q1 2021 -$28.1M -$2.37M -9.21% Feb 28, 2021 10-Q 2021-04-14
Q4 2020 -$28.5M -$3.72M -15% Nov 30, 2020 10-Q 2021-01-14
Q3 2020 -$27.8M -$3.93M -16.5% Aug 31, 2020 10-K 2021-11-29
Q2 2020 -$27.1M -$4.3M -18.9% May 31, 2020 10-Q 2020-06-30
Q1 2020 -$25.7M -$4.11M -19% Feb 29, 2020 10-Q 2020-04-03
Q4 2019 -$24.8M -$4.31M -21% Nov 30, 2019 10-Q 2020-01-09
Q3 2019 -$23.9M -$4.1M -20.7% Aug 31, 2019 10-K 2020-10-15
Q2 2019 -$22.8M -$4.24M -22.8% May 31, 2019 10-Q 2019-07-08
Q1 2019 -$21.6M -$6.49M -42.9% Feb 28, 2019 10-Q 2019-04-15
Q4 2018 -$20.5M -$6.72M -48.9% Nov 30, 2018 10-Q 2019-01-11
Q3 2018 -$19.8M -$6.6M -50.1% Aug 31, 2018 10-K 2019-11-14
Q2 2018 -$18.6M -$6.07M -48.6% May 31, 2018 10-Q 2018-07-13
Q1 2018 -$15.1M -$2.98M -24.6% Feb 28, 2018 10-Q 2018-04-12
Q4 2017 -$13.7M -$2.05M -17.5% Nov 30, 2017 10-Q 2018-01-12
Q3 2017 -$13.2M -$1.87M -16.5% Aug 31, 2017 10-K 2018-11-14
Q2 2017 -$12.5M -$1.5M -13.6% May 31, 2017 10-Q 2017-07-14
Q1 2017 -$12.1M -$1.42M -13.2% Feb 28, 2017 10-Q 2017-04-14
Q4 2016 -$11.7M -$1.23M -11.7% Nov 30, 2016 10-Q 2017-01-13
Q3 2016 -$11.3M -$1.21M -12% Aug 31, 2016 10-K 2017-11-27
Q2 2016 -$11M -$1.42M -14.8% May 31, 2016 10-Q 2016-07-13
Q1 2016 -$10.7M -$1.63M -17.9% Feb 29, 2016 10-Q 2016-04-13
Q4 2015 -$10.5M -$1.81M -20.8% Nov 30, 2015 10-Q 2016-01-08
Q3 2015 -$10.1M -$1.77M -21.3% Aug 31, 2015 10-K 2016-11-29
Q2 2015 -$9.57M -$3.34M -53.6% May 31, 2015 10-Q 2015-07-14
Q1 2015 -$9.1M -$3.45M -61% Feb 28, 2015 10-Q 2015-04-14
Q4 2014 -$8.66M -$3.5M -67.9% Nov 30, 2014 10-Q 2015-01-14
Q3 2014 -$8.32M -$3.26M -64.4% Aug 31, 2014 10-K 2015-11-27
Q2 2014 -$6.23M -$1.3M -26.3% Jul 31, 2014 10-Q/A 2014-11-14
Q1 2014 -$5.65M -$779K -16% Apr 30, 2014 10-Q 2014-06-12
Q4 2013 -$5.16M -$333K -6.91% Jan 31, 2014 10-Q 2014-03-12
Q3 2013 -$5.06M -$344K -7.29% Oct 31, 2013 10-KT 2014-12-09
Q2 2013 -$4.93M -$186K -3.92% Jul 31, 2013 10-Q 2013-09-10
Q1 2013 -$4.87M -$60.1K -1.25% Apr 30, 2013 10-Q 2013-06-12
Q4 2012 -$4.83M -$245K -5.34% Jan 31, 2013 10-Q 2013-03-13
Q3 2012 -$4.71M -$252K -5.64% Oct 31, 2012 10-K 2014-01-24
Q2 2012 -$4.75M -$282K -6.32% Jul 31, 2012 10-Q 2012-09-12
Q1 2012 -$4.81M Apr 30, 2012 10-Q 2012-06-07
Q4 2011 -$4.58M Jan 31, 2012 10-Q 2012-03-13
Q3 2011 -$4.46M -$538K -13.7% Oct 31, 2011 10-K 2013-01-29
Q2 2011 -$4.46M Jul 31, 2011 10-Q 2011-09-14
Q3 2010 -$3.92M Oct 31, 2010 10-K 2012-01-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.